Twist Bioscience Corp — Director's Dealing 2019

Aug 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-05-20

Reporting Person: CHAN NELSON C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-21	Common Stock	A	1497	$0.00	Acquired	1497	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-20	Director Stock Option (right to buy)	$25.29	A	13444	Acquired	2029-05-19	Common Stock (13444)	Direct
2019-06-21	Director Stock Option (right to buy)	$30.08	A	3093	Acquired	2029-06-20	Common Stock (3093)	Direct

Footnotes

F1: Represents a restricted stock unit award that has fully vested.

F2: 1/3rd of the shares subject to the option will vest and become exercisable on May 20, 2020 and each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F3: The stock option has fully vested and is immediately exercisable.